Clinical Trial

Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpA

Study acronym: NJSpAM
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 17, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to further improve and expand the WB-MRI imaging evaluation cohort of axSpA patients to complete dynamic follow-up and condition assessment. Based on the WB-MRI features, the association of WB-MRI signs with disease activity, inflammation, and structural damage will be analyzed. At the same time, in-depth data mining was conducted and machine learning was used to construct a new axSpA disease activity assessment model based on WB-MRI data, and the accuracy and reliability of the model were clearly evaluated in the discovery cohort and validation cohort.
Trial Details
NCT Number NCT07230327
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Conditions Spondyloarthritis (SpA), Whole-body MRI (WBMRI)
Enrollment 100 participants
Start Date 2022-01-01
Primary Completion 2026-01 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-17